These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30181135)

  • 21. Alternating Modulation of Subthalamic Nucleus Beta Oscillations during Stepping.
    Fischer P; Chen CC; Chang YJ; Yeh CH; Pogosyan A; Herz DM; Cheeran B; Green AL; Aziz TZ; Hyam J; Little S; Foltynie T; Limousin P; Zrinzo L; Hasegawa H; Samuel M; Ashkan K; Brown P; Tan H
    J Neurosci; 2018 May; 38(22):5111-5121. PubMed ID: 29760182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subthalamic beta oscillations correlate with dopaminergic degeneration in experimental parkinsonism.
    Haumesser JK; Beck MH; Pellegrini F; Kühn J; Neumann WJ; Altschüler J; Harnack D; Kupsch A; Nikulin VV; Kühn AA; van Riesen C
    Exp Neurol; 2021 Jan; 335():113513. PubMed ID: 33148526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary roles of different oscillatory activities in the subthalamic nucleus in coding motor effort in Parkinsonism.
    Tan H; Pogosyan A; Anzak A; Ashkan K; Bogdanovic M; Green AL; Aziz T; Foltynie T; Limousin P; Zrinzo L; Brown P
    Exp Neurol; 2013 Oct; 248():187-95. PubMed ID: 23778147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease.
    van Wijk BC; Beudel M; Jha A; Oswal A; Foltynie T; Hariz MI; Limousin P; Zrinzo L; Aziz TZ; Green AL; Brown P; Litvak V
    Clin Neurophysiol; 2016 Apr; 127(4):2010-9. PubMed ID: 26971483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levodopa-induced modulation of subthalamic beta oscillations during self-paced movements in patients with Parkinson's disease.
    Doyle LM; Kühn AA; Hariz M; Kupsch A; Schneider GH; Brown P
    Eur J Neurosci; 2005 Mar; 21(5):1403-12. PubMed ID: 15813950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The modulatory effect of adaptive deep brain stimulation on beta bursts in Parkinson's disease.
    Tinkhauser G; Pogosyan A; Little S; Beudel M; Herz DM; Tan H; Brown P
    Brain; 2017 Apr; 140(4):1053-1067. PubMed ID: 28334851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthalamic nucleus activity dynamics and limb movement prediction in Parkinson's disease.
    Khawaldeh S; Tinkhauser G; Shah SA; Peterman K; Debove I; Nguyen TAK; Nowacki A; Lachenmayer ML; Schuepbach M; Pollo C; Krack P; Woolrich M; Brown P
    Brain; 2020 Feb; 143(2):582-596. PubMed ID: 32040563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive factors modulate activity within the human subthalamic nucleus during voluntary movement in Parkinson's disease.
    Oswal A; Litvak V; Brücke C; Huebl J; Schneider GH; Kühn AA; Brown P
    J Neurosci; 2013 Oct; 33(40):15815-26. PubMed ID: 24089489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
    Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
    J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine-dependent scaling of subthalamic gamma bursts with movement velocity in patients with Parkinson's disease.
    Lofredi R; Neumann WJ; Bock A; Horn A; Huebl J; Siegert S; Schneider GH; Krauss JK; Kühn AA
    Elife; 2018 Feb; 7():. PubMed ID: 29388913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease.
    Zaidel A; Spivak A; Grieb B; Bergman H; Israel Z
    Brain; 2010 Jul; 133(Pt 7):2007-21. PubMed ID: 20534648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of inter-electrode distance on subthalamic nucleus local field potential recordings in Parkinson's disease.
    Averna A; Marceglia S; Arlotti M; Locatelli M; Rampini P; Priori A; Bocci T
    Clin Neurophysiol; 2022 Jan; 133():29-38. PubMed ID: 34794045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease.
    Hirschmann J; Hartmann CJ; Butz M; Hoogenboom N; Ozkurt TE; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Brain; 2013 Dec; 136(Pt 12):3659-70. PubMed ID: 24154618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of Medication on the Oscillatory and Dynamic Characteristics of Subthalamic Local Field Potentials in Patients with Parkinson's Disease].
    Wang Y; Geng X; Huang Y; Wang S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):49-55. PubMed ID: 27382739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative phases of basal ganglia activities dynamically shape effective connectivity in Parkinson's disease.
    Cagnan H; Duff EP; Brown P
    Brain; 2015 Jun; 138(Pt 6):1667-78. PubMed ID: 25888552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.
    Anidi C; O'Day JJ; Anderson RW; Afzal MF; Syrkin-Nikolau J; Velisar A; Bronte-Stewart HM
    Neurobiol Dis; 2018 Dec; 120():107-117. PubMed ID: 30196050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of dopa and subthalamic stimulation on vestibular activity in Parkinson's disease.
    Pötter-Nerger M; Reich MM; Colebatch JG; Deuschl G; Volkmann J
    Mov Disord; 2012 Sep; 27(10):1268-75. PubMed ID: 22693156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subthalamic nucleus activity dissociates proactive and reactive inhibition in patients with Parkinson's disease.
    Benis D; David O; Lachaux JP; Seigneuret E; Krack P; Fraix V; Chabardès S; Bastin J
    Neuroimage; 2014 May; 91():273-81. PubMed ID: 24368260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between oscillatory activity and motor reaction time in the parkinsonian subthalamic nucleus.
    Williams D; Kühn A; Kupsch A; Tijssen M; van Bruggen G; Speelman H; Hotton G; Loukas C; Brown P
    Eur J Neurosci; 2005 Jan; 21(1):249-58. PubMed ID: 15654862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.